Zimmer Biomet completed the spin-off of ZimVie in a $820m deal.

Zimmer Biomet, a global medical technology provider, completed the spin-off of ZimVie, a dental and spine businesses, in a $820m deal. "We are confident that this transaction will create shareholder value for both companies and will allow us to increase our focus and enhance revenue growth for our core businesses," Bryan Hanson, Zimmer Biomet Chairman, President and CEO.